Scientech Research LLC Sells 521 Shares of Zoetis Inc. (NYSE:ZTS)

Scientech Research LLC decreased its stake in shares of Zoetis Inc. (NYSE:ZTS) by 9.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,898 shares of the company’s stock after selling 521 shares during the period. Scientech Research LLC’s holdings in Zoetis were worth $849,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ZTS. Aveo Capital Partners LLC acquired a new stake in Zoetis in the fourth quarter worth about $225,000. Gryphon Financial Partners LLC grew its position in shares of Zoetis by 11.8% during the 4th quarter. Gryphon Financial Partners LLC now owns 3,056 shares of the company’s stock worth $601,000 after buying an additional 322 shares during the period. Evoke Wealth LLC raised its stake in shares of Zoetis by 14.1% during the fourth quarter. Evoke Wealth LLC now owns 1,675 shares of the company’s stock worth $331,000 after buying an additional 207 shares during the last quarter. Tradition Wealth Management LLC lifted its holdings in Zoetis by 24.9% in the fourth quarter. Tradition Wealth Management LLC now owns 1,074 shares of the company’s stock valued at $212,000 after buying an additional 214 shares during the period. Finally, Partners Capital Investment Group LLP lifted its holdings in Zoetis by 49.5% in the fourth quarter. Partners Capital Investment Group LLP now owns 1,805 shares of the company’s stock valued at $356,000 after buying an additional 598 shares during the period. Institutional investors and hedge funds own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have commented on ZTS. BTIG Research upped their target price on shares of Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, August 12th. Stifel Nicolaus upped their price objective on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a report on Wednesday, September 18th. Piper Sandler increased their target price on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 14th. Finally, Argus upgraded Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Nine research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Zoetis currently has an average rating of “Buy” and a consensus target price of $220.38.

Zoetis Stock Down 0.0 %

Shares of Zoetis stock opened at $194.81 on Friday. The company has a market capitalization of $88.89 billion, a P/E ratio of 37.54, a price-to-earnings-growth ratio of 2.97 and a beta of 0.88. The company has a debt-to-equity ratio of 1.32, a current ratio of 3.45 and a quick ratio of 2.09. The business has a 50-day moving average of $186.04 and a two-hundred day moving average of $174.79. Zoetis Inc. has a 1 year low of $144.80 and a 1 year high of $201.92.

Zoetis (NYSE:ZTS) last announced its earnings results on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, topping the consensus estimate of $1.49 by $0.07. The firm had revenue of $2.36 billion for the quarter, compared to the consensus estimate of $2.31 billion. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The business’s quarterly revenue was up 8.3% on a year-over-year basis. During the same period last year, the company posted $1.41 EPS. As a group, equities analysts predict that Zoetis Inc. will post 5.84 EPS for the current year.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.